Rakuten Securities’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Rakuten Securities's BMY Position: Q2 2026 in Review
Rakuten Securities reduced its Bristol-Myers Squibb (BMY) stake by 64% in Q2 2026, selling an estimated $5.91K and leaving 59 shares worth $3.4K. The position accounts for ﹤0.01% of the portfolio, ranked #598.
Rakuten Securities first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $112K in Q1 2024. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Rakuten Securities held 59 shares of Bristol-Myers Squibb worth $3.4K as of Q2 2026.
- Rakuten Securities sold 103 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.91K.
- Bristol-Myers Squibb made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #598 holding.
- Rakuten Securities first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Rakuten Securities's Bristol-Myers Squibb position peaked at $112K in Q1 2024.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.